Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6694396> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Q6694396 subject Q5920511.
- Q6694396 subject Q7334131.
- Q6694396 subject Q8503312.
- Q6694396 subject Q8872471.
- Q6694396 subject Q8878420.
- Q6694396 subject Q8965786.
- Q6694396 abstract "Lavoltidine (INN, USAN, BAN; previously known as loxtidine, code name AH-23,844) is a highly potent and selective H2 receptor antagonist which was under development by Glaxo Wellcome (now GlaxoSmithKline) as a treatment for gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid tumors in rodents.".
- Q6694396 atcPrefix "none".
- Q6694396 casNumber "76956-02-0".
- Q6694396 fdaUniiCode "X16K5179V5".
- Q6694396 iupacName "[1-methyl-5-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]-1,2,4-triazol-3-yl]methanol".
- Q6694396 pubchem "55473".
- Q6694396 thumbnail Lavoltidine.svg?width=300.
- Q6694396 wikiPageWikiLink Q104116.
- Q6694396 wikiPageWikiLink Q14877295.
- Q6694396 wikiPageWikiLink Q1734755.
- Q6694396 wikiPageWikiLink Q2066956.
- Q6694396 wikiPageWikiLink Q212322.
- Q6694396 wikiPageWikiLink Q223591.
- Q6694396 wikiPageWikiLink Q409444.
- Q6694396 wikiPageWikiLink Q410943.
- Q6694396 wikiPageWikiLink Q411193.
- Q6694396 wikiPageWikiLink Q4914025.
- Q6694396 wikiPageWikiLink Q4926095.
- Q6694396 wikiPageWikiLink Q5920511.
- Q6694396 wikiPageWikiLink Q7334131.
- Q6694396 wikiPageWikiLink Q824258.
- Q6694396 wikiPageWikiLink Q8503312.
- Q6694396 wikiPageWikiLink Q8872471.
- Q6694396 wikiPageWikiLink Q8878420.
- Q6694396 wikiPageWikiLink Q8965786.
- Q6694396 wikiPageWikiLink Q918753.
- Q6694396 atcPrefix "none".
- Q6694396 casNumber "76956".
- Q6694396 iupacName "[1-methyl-5-[3-[3-phenoxy]propylamino]-1,2,4-triazol-3-yl]methanol".
- Q6694396 pubchem "55473".
- Q6694396 unii "X16K5179V5".
- Q6694396 type ChemicalSubstance.
- Q6694396 type Drug.
- Q6694396 type ChemicalObject.
- Q6694396 type Thing.
- Q6694396 type Q8386.
- Q6694396 comment "Lavoltidine (INN, USAN, BAN; previously known as loxtidine, code name AH-23,844) is a highly potent and selective H2 receptor antagonist which was under development by Glaxo Wellcome (now GlaxoSmithKline) as a treatment for gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid tumors in rodents.".
- Q6694396 label "Lavoltidine".
- Q6694396 depiction Lavoltidine.svg.